Barrick's NewCo Progress De-risks IPO but Valuation Nears Trim Level

What happened

Barrick's Q2 results were mixed, with gold production beating guidance but AISC up 11% YoY and free cash flow dented by a one-time Mali payment, though the balance sheet remains strong. The company announced a JV agreement with Newmont that clears a key hurdle for the planned North American IPO, enabling separation of high-quality assets and a return of most net proceeds to shareholders. This addresses a prior thesis breaker: the need for explicit Newmont consent and NewCo structure details by mid-2026, which had kept DeepValue on a WAIT rating. However, the stock has appreciated ~20% since late February, pushing it near the $55 trim level identified in the master report, while cost inflation and project execution risks persist. The market now prices substantial value unlock, leaving limited margin of safety for new positions.

Implication

The clearing of Newmont's JV consent removes a major binary risk, but the stock's run to near the $55 trim threshold means risk/reward is no longer attractive for adding. AISC inflation of 11% and the one-time Mali payment signal that free cash flow may be under pressure in 2026, potentially reducing payouts under the 50% framework. While the IPO may unlock value, execution risks (governance, carve-out, market conditions) and elevated capex guidance of $4.0B-$4.45B could still disappoint. Barrick's balance sheet strength provides downside support, but the master report's bear case implied value of $38 is not far below current levels if capex overshoots or Reko Diq slips. On balance, we shift from WAIT to TRIM/SELL into strength, preferring to reassess after Q3 results or NewCo prospectus details.

Thesis delta

The prior thesis hinged on waiting for NewCo terms and Newmont consent by mid-2026; the JV agreement satisfies that condition. However, the stock's appreciation to near the $55 trim level and persistent cost pressures warrant a downgrade from WAIT to TRIM/SELL. The risk/reward now skews negative as the IPO catalyst is largely de-risked and reflected in valuation.